Multiple System Atrophy
150
36
49
63
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
18 trials with published results (12%)
Research Maturity
63 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.0%
12 terminated out of 150 trials
84.0%
-2.5% vs benchmark
6%
9 trials in Phase 3/4
29%
18 of 63 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 63 completed trials
Clinical Trials (150)
Prospective Multicenter Registry Study of Multiple System Atrophy in China
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Natural History Study of Synucleinopathies
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study
A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)
A Study of TAK-341 in Treatment of Multiple System Atrophy
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy
Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)
North American Prodromal Synucleinopathy Consortium Stage 2
Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their Caregivers
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy
Automated Abdominal Binder for Orthostatic Hypotension
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
Clinical Laboratory Evaluation of Chronic Autonomic Failure